CJC-1295 + Ipamorelin

10 MG / VIAL>99% HPLCPGX-CJI-10

PURITY

>99%

FORMAT

Lyophilized

DOSE

10 mg / vial

STORAGE

2–8°C

INCLUDED WITH VIAL

Each vial ships with its respective reconstitution water.

VIEW RECONSTITUTION WATER

Overview

This combination consists of two peptides studied for their interaction with pathways related to the pulsatile secretion of growth hormone and endocrine regulation in controlled research environments. CJC-1295 (No DAC) extends the signaling window of growth-hormone releasing hormone, while Ipamorelin selectively engages the ghrelin receptor to trigger pulsatile GH release — making the pair a widely referenced model for studying endogenous GH rhythms.

Research areas

01
Growth hormone (GH) signaling and release
02
Endocrine and neuroendocrine regulation
03
Metabolic processes associated with hormonal signaling
04
Growth biomarkers in experimental models
05
Biological aging studies

Specifications

COMPOSITION: CJC-1295 (No DAC) + Ipamorelin
PURITY: >99% (HPLC)
FORMAT: Lyophilized vial
STORAGE: 2–8°C
HANDLING: Research use only

Handling protocol

COLD CHAIN

2–8°C

PROTECTION

Light-shielded

USE

Research only

Scientific notes

Both compounds are frequently studied together because of their complementary action on the physiological release of GH — CJC-1295 (No DAC) sustains the GHRH signaling envelope, while Ipamorelin selectively triggers pulsatile secretion via the ghrelin receptor without disrupting cortisol or prolactin axes.

RESEARCH USE ONLY · NOT FOR HUMAN CONSUMPTION

Get it now Contact

Other compounds in the catalog